Evidence map›Paper›PMID 42266556›Full record

ArticleKidney international reports2026

Executive Summary of Evidence-Based Guidelines for the Diagnosis and Treatment of Pediatric CKD-Mineral and Bone Disorder (Version 2024).

Mo Wang, Hua-Ying Xiong, Chunhua Zhu, Xinyi Yu, Jia Jiao, Liwen Tan, Ying Shen, Hong Xu, Jianhua Mao, Jianhua Zhou and 24 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney international reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Mo WangDepartment of Nephrology, Children's Hospital of Chongqing Medical University, Chongqing, China.
Hua-Ying XiongDepartment of Nephrology, Children's Hospital of Chongqing Medical University, Chongqing, China.
Chunhua ZhuDepartment of Pediatric Nephrology, Children's Hospital of Nanjing Medical University, Nanjing, China.
Xinyi YuDepartment of Nephrology, Children's Hospital of Chongqing Medical University, Chongqing, China.
Jia JiaoDepartment of Nephrology, Children's Hospital of Chongqing Medical University, Chongqing, China.
Liwen TanDepartment of Nephrology, Children's Hospital of Chongqing Medical University, Chongqing, China.
Ying ShenDepartment of Nephrology, Beijing Children's Hospital, Capital Medical University, Beijing, China.
Hong XuDepartment of Nephrology, Children's Hospital of Fudan University, Shanghai, China.
Jianhua MaoDepartment of Nephrology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Jianhua ZhouDepartment of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China.
Xiao-Yun JiangDepartment of Pediatric Rheumatology and Nephrology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, China.
Qian ShenDepartment of Nephrology, Children's Hospital of Fudan University, Shanghai, China.
Fang WangDepartment of Pediatrics, Peking University First Hospital, Beijing, China.
Songming HuangDepartment of Pediatric Nephrology, Children's Hospital of Nanjing Medical University, Nanjing, China.
Wenyan HuangDepartment of Nephrology, Rheumatology and Immunology, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai, China.
Zheng-Kun XiaDepartment of Pediatrics, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.
Xiao-Rong LiuDepartment of Nephrology, Beijing Children's Hospital, Capital Medical University, Beijing, China.
Hui WangDepartment of Nephrology, Beijing Children's Hospital, Capital Medical University, Beijing, China.
Yu-Bin WuDepartment of Pediatric Nephrology, Shengjing Hospital of China Medical University, Shenyang, China.
Li YuDepartment of Pediatrics, Guangzhou First People's Hospital, Guangzhou, China.
Yu-Hong TaoDepartment of Pediatric Nephrology, West China Second University Hospital of Sichuan University, Chengdu, China.
Chun-Lin GaoDepartment of Pediatrics, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.
Ying-Jie LiDepartment of Nephrology, Guangzhou Women and Children's Medical Center, Guangzhou, China.
Shu-Zhen SunDepartment of Pediatrics, Shandong Provincial Hospital, Jinan, China.
Dong-Feng ZhangDepartment of Nephrology and Immunology, Hebei Children's Hospital, Shijiazhuang, China.
Xiao-Shan ShaoDepartment of Pediatric Rheumatology and Immunology, Guiyang Maternal and Child Health Hospital, Guiyang, China.
Li-Jun ZhaoDepartment of Nephrology, Shanxi Children's Hospital, Taiyuan, China.
Xiaowen WangDepartment of Nephrology, Wuhan Children's Hospital, Wuhan, China.
Xi-Qiang DangDepartment of Pediatrics Nephrology, Second Xiangya Hospital of Central South University, Changsha, China.
Hui-Mei HuangDepartment of Nephrology, Xi'an Children's Hospital, Xi'an, China.
Yaolong ChenThe Centre of Evidence-based Social Science, School of Public Health, Lanzhou University, Lanzhou, China.
Qiu LiDepartment of Nephrology, Children's Hospital of Chongqing Medical University, Chongqing, China.
Aihua ZhangDepartment of Pediatric Nephrology, Children's Hospital of Nanjing Medical University, Nanjing, China.
Subspecialty Group of Nephrology, the Society of Pediatrics, Chinese Medical Association

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) in children refers to the systemic mineral and bone metabolism disorders caused by CKD, including biochemical abnormalities, abnormalities in bone turnover, mineralization, quality, and ectopic calcification. Like adult patients, mineral metabolism and bone structure abnormalities are universally present in children with CKD. However, there have been no guidelines specifically for children in the past. The medication treatment and clinical practices for children are usually based on those for adults, thus lacking targeted guidance. Children are in the process of growth and development, and adult guidelines do not take into account the characteristics of children. In addition, the medication range for children is different from that of adults, and new drugs have been verified and tested in children. Therefore, based on the developmental characteristics of children, combined with expert opinions about adults, children, kidney, nutrition, and medicine, this guideline was initiated by the Subspecialty Group of Nephrology, the Society of Pediatrics, Chinese Medical Association. It answers many important clinical questions related to the diagnosis and treatment of pediatric CKD-MBD, aims to provide individualized treatment plans considering the clinical characteristics of children with CKD and their treatment goals, while addressing the needs of their growth and development.

Indexed as

childrenCKD-MBDdiagnosisevaluationguidelinetreatment

Identifiers

PMID42266556
PMCPMC13244302

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.